SCHEMBL6636883

SCHEMBL6636883

Cn1c(COc2cccc(C#N)c2)nc2cc(NS(=O)(=O)c3ccccc3)ccc21

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.56
PAX8 Q06710 4/20 0.55
POLB P06746 1/20 0.55
LMNA P02545 2/20 0.54
F2 P00734 2/20 0.51
BRD1 O95696 1/20 0.51
BRPF1 P55201 1/20 0.51
HDAC6 Q9UBN7 1/20 0.49
PGR P06401 1/20 0.49
ALDH1A1 P00352 2/20 0.49
PKM P14618 1/20 0.49
PPARG P37231 1/20 0.49
NPC1 O15118 1/20 0.47
RAB9A P51151 1/20 0.47
AR P10275 1/20 0.46
MAPT P10636 1/20 0.46
HPGD P15428 1/20 0.46
HTT P42858 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
TP53 P04637 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6638828 0.85 F2 (0.58) F2ALDH1A1PKMPPARGHTT
SCHEMBL6639365 0.84 F2 (0.68) SMN1; SMN2PAX8POLBLMNAF2
SCHEMBL8027058 0.81 F2 (0.70) SMN1; SMN2PAX8POLBLMNAF2
SCHEMBL6637025 0.80 PAX8 (0.64) SMN1; SMN2PAX8POLBLMNAF2
Pyrrole SCHEMBL6782101 0.78 HTR2C (0.51) SMN1; SMN2HDAC6PPARGNPC1RAB9A
SCHEMBL6782097 0.78 HTR2C (0.50) SMN1; SMN2LMNAHDAC6ALDH1A1PPARG
SCHEMBL6635871 0.76 BRPF1 (0.48) SMN1; SMN2PAX8POLBLMNAF2
SCHEMBL6636886 0.76 BRPF1 (0.52) SMN1; SMN2PAX8POLBLMNAF2
SCHEMBL6638614 0.74 F2 (0.43) SMN1; SMN2PAX8POLBLMNAF2
SCHEMBL8032270 0.74 F2 (0.72) SMN1; SMN2PAX8POLBLMNAF2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1100795-B1 DISUBSTITUTED BICYCLIC HETEROCYCLES HAVING, IN PARTICULAR, A THROMBIN INHIBITIVE EFFECT BOEHRINGER INGELHEIM PHARMA (DE) 2004-06-09 EP disclosed
US-6121308-A INDOLE AND BENZIMIDAZOLE ANTITHROMBOTIC COMPOUNDS, SUCH AS 1-METHYL-2-(N-(4-AMIDINOPHENYL)-AMINOMETHYL)-5-(N-(HYDROXYCARBONYLMETHYL) -QUINOLINE-8-SULPHONYLAMINO)-INDOLE BOEHRINGER INGELHEIM KG (DE) 2000-09-19 US disclosed